How to Watch the FDA Advisory Committee Meeting

On Thursday, November 4, 2021 from 8:45 a.m. to 3:30 p.m. EST, the U.S. Food and Drug Administration (FDA) will hold an Advisory Committee Meeting to discuss the new drug application (NDA) 214812, for carbetocin nasal spray, submitted by Levo Therapeutics, Inc., for the proposed treatment of hyperphagia, anxiety, and distress behaviors associated with Prader-Willi syndrome. The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform, which can be found HERE. Anyone can join the virtual meeting for free. There will also be a recording available following the meeting.

Share this!

Scroll to top